Improving adequacy improves haemodialysis outcome

EDTNA-ERCA Journal

Volumn 26, Issue 1, 2000, Pages 6-10

  Charra, B ^a  

^a Centre de Rein Artificial   (France)

Author keywords

Blood pressure; Haemodialysis; Morbidity; Mortality; Optimal dialysis

Indexed keywords

ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; EXTRACELLULAR SPACE; HEMODIALYSIS; HUMAN; MORBIDITY; MORTALITY; NUTRITION; TREATMENT OUTCOME; UREA BLOOD LEVEL;

EID: 0034513818     PISSN: 1019083X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1755-6686.2000.tb00068.x     Document Type: Article

References (51)

1. "Adequacy" of haemodialysis
2. The genesis of the square meter-hour hypothesis
3. Effect of the haemodialysis prescription on patient morbidity. Report from the National Cooperative Study
4. A Mechanistic analysis of the National Cooperative Study (NCDS)
5. Proceedings from the morbidity, mortality and prescription of dialysis symposium, Dallas, Texas, September 1989: Introduction and summary
6. The influence of urea kinetic modelling (UKM) on gross mortality in haemodialysis
7. Survival of haemodialysis patients in United States is improved with a greater quantity of dialysis
8. Effects of dose of dialysis on morbidity and mortality
9. Extracellular volume innocturnal haemodialysis
10. A theoretical definition of minimal acceptable dialysis therapy
11. Adequacy of haemodialysis
12. Behind the scenes of the NKF-DOQI guidelines. Haemodialysis adequacy
13. The haemodialysis (HEMO) study: Rationale for selection of interventions
14. Quantitation of dialysis: The importance of membrane and middle molecules
15. Why Are Dialysis Patients Malnourished?
16. Modelling and the middle molecule
17. Effect of dialysis membranes and middle molecule removal on chronic haemodialysis patient survival
18. Malnutrition as the main factor in morbidity and mortality of dialysis patients
19. Death risk in haemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities
20. Nutrition and adequacy of dialysis in haemodialysis patients
21. The effect of malnutrition on cardiovascular mortality in dialysis patients: Is L-Arginine the answer?
22. Nutritional status and survival in end-stage renal disease patients
23. Which comes first, Kt/V or PCR-Chicken or egg?
24. Middle molecules isolated from uraemic ultrafiltrate and normal urine induce dose-dependent inhibition of appetite in rat
25. Dietary intake and left ventricular hypertrophy
26. The management of congestive heart failure in uraemic patients
27. Assessment of dry weight in haemodialysis: An overview
28. Clinical assessment of dry weight
29. Interdialysis blood pressure control by long haemodialysis sessions
30. High incidence of symmetrical LVH in long-term HD patients, despite excellent BP control
31. Sodium flux and dialysate sodium in haemodialysis
32. Sodium retention and hypertension with short dialysis
33. Short-term dialysis, long-term complications
34. Report on management of renal failure in Europe XXII
35. Blood Pressure, hearts, and U-shaped curves
36. The 6th report of Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure
37. Blood pressure control in patients with end-stage renal failure treated by intermittent dialysis
38. Hypertension in end-stage renal disease
39. Role of the kidneyin "salt and water dependent hypertension" of end-stage renal disease
40. Combined report on regular dialysis and transplantation in Europe
41. Interdialytic hypertension
42. Dialysis hypotension: Is it related to diastolic left ventricular malfunction?
43. The "unphysiology" of dialysis: A major cause of dialysis side effects?
44. Prevalence of missed treatments and early sign-offs in haemodialysis patients
45. Mortality and duration of haemodialysis treatment
46. Current status of renal replacement therapy in Japan: Results of the annual survey of the Japanese Society for Dialysis Therapy
47. Daily dialysis: Long term clinical metabolic results
48. Dialysis with increased frequency of sessions (Lecce dialysis)
49. Daily home haemodialysis in The Netherlands: Effects on metabolic control, haemodynamics, and quality of life
50. Nocturnal haemodialysis: Three-year experience